Ethos Financial Group, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Ethos Financial Group, LLC
- $568 Million
- Q2 2024
A detailed history of Ethos Financial Group, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Ethos Financial Group, LLC holds 312,000 shares of DNA stock, worth $2.61 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
312,000
Previous 18,000
1633.33%
Holding current value
$2.61 Million
Previous $21,000
395.24%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DNA
# of Institutions
339Shares Held
924MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.16 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.13 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$585 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$352 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...